ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Research Progress on Commonly Used Antifungal Drugs and Their Resistance Mechanisms Against Candida Albicans Infections
June 28, 2024Candida albicans is the primary cause of candidiasis, an acute, subacute, or chronic infection that poses a severe threat to human health due to its complex and varying clinical symptoms. -
Microbial compound in new fluconazole formulation used to combat Candida albicans
April 29, 2020Researchers have used a specific chemical signal released from a major bacterial pathogen to improve the activity of fluconazole against Candida biofilms.
Pharma Sources Insight January 2025
